Latest Asx News

Pacgold has completed its maiden drilling at White Lion, intersecting promising gold mineralisation, while extending the Jerry Dodds lode strike to 1.8km, both discoveries supporting further exploration in 2026.

Hamelin Gold has extended shallow gold mineralisation at its Fremlins South prospect to over 400 metres strike and identified a 500-metre mineralised trend at Jazz, with follow-up drilling planned for early 2026.

Bio-Gene Technology’s natural insecticide Qcide® has earned organic listing status from the US Organic Materials Review Institute, marking a pivotal step for its entry into the organic pest control market.

Suzerain Investment Holdings Ltd has initiated an off-market takeover offer for all remaining shares in Entertainment Rewards Ltd at a significant premium, aiming to consolidate full ownership and potentially delist the company from the ASX.

Nimy Resources announces a maiden JORC Inferred Mineral Resource at its Mons Block 3 project in Western Australia, featuring exceptionally high-grade gallium and significant rare earth oxides, positioning the company as a potential key supplier amid global supply constraints.

Panther Metals has extended the closing date of its non-renounceable rights issue to 28 November 2025, providing eligible shareholders more time to consider and participate in the capital raising.

The Supreme Court of Western Australia has approved the share and option schemes for Capricorn Metals’ acquisition of Warriedar Resources, setting the stage for a significant consolidation in the gold exploration sector.

Novatti Group has attracted a $1 million investment from Australian Wealth Advisors Group to fuel its renewed growth strategy, focusing on expanding its Acquiring business following positive early financial results.

Tombador Iron Limited has completed its strategic acquisition of GoviEx Uranium Inc., paving the way for a relisting as Atomic Eagle Ltd focused on uranium exploration.

Sequoia Financial Group’s subsidiary InterPrac Financial Planning faces ASIC civil penalty proceedings over past investment advice but plans a robust defence.

Island Pharmaceuticals will host a webinar to discuss the FDA's feedback on the clinical development and regulatory approval of its antiviral drug Galidesivir, including key considerations under the FDA's Animal Rule and Priority Review Voucher eligibility.

Volt Group Limited is set to acquire Perth-based 4D Delta Pty Ltd for $7.25 million, adding a profitable digital asset inspection business to its portfolio. The acquisition is supported by a $4 million capital raise and aims to accelerate Volt’s growth in technology-enabled resource services.